Ho RJ[au] - Search Results

Year	Number of Results
1964	2
1965	2
1966	2
1967	3
1969	1
1970	5
1971	2
1972	1
1973	1
1975	5
1977	1
1978	3
1979	1
1980	1
1981	3
1983	2
1984	1
1985	1
1986	8
1987	2
1988	2
1989	1
1990	1
1991	1
1992	1
1993	1
1994	7
1995	6
1996	2
1997	4
1998	1
1999	3
2000	5
2001	4
2002	2
2003	3
2004	6
2005	4
2006	6
2007	4
2008	7
2009	2
2010	5
2011	9
2012	5
2013	3
2014	9
2015	11
2016	5
2017	5
2018	9
2019	4
2020	14
2021	8
2022	2

1

Editorial: human genome information.

Ho RJ. Ho RJ. J Pharm Sci. 2011 Oct;100(10):4045-6. doi: 10.1002/jps.22713. Epub 2011 Jul 20. J Pharm Sci. 2011. PMID: 21780123 Free PMC article. No abstract available.

2

Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook.

Mu Q, Yu J, McConnachie LA, Kraft JC, Gao Y, Gulati GK, Ho RJY. Mu Q, et al. Among authors: ho rjy. J Drug Target. 2018 Jun-Jul;26(5-6):435-447. doi: 10.1080/1061186X.2017.1419363. Epub 2018 Jan 10. J Drug Target. 2018. PMID: 29285948 Free PMC article. Review.

3

Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy.

Gao Y, Kraft JC, Yu D, Ho RJY. Gao Y, et al. Among authors: ho rjy. Eur J Pharm Biopharm. 2019 May;138:75-91. doi: 10.1016/j.ejpb.2018.04.014. Epub 2018 Apr 17. Eur J Pharm Biopharm. 2019. PMID: 29678735 Free PMC article. Review.

4

Optimizing a Novel Au-Grafted Lipid Nanoparticle Through Chelation Chemistry for High Photothermal Biologic Activity.

Gao Y, Mu Q, Zhu L, Li Z, Ho RJY. Gao Y, et al. Among authors: ho rjy. J Pharm Sci. 2020 May;109(5):1780-1788. doi: 10.1016/j.xphs.2020.02.010. Epub 2020 Feb 18. J Pharm Sci. 2020. PMID: 32081720

5

Advancing Cell and Gene Therapeutic Products for Health Impact - Progress on Pharmaceutical Research, Development, Manufacturing and Controls.

Bak A, Ho RJY. Bak A, et al. Among authors: ho rjy. J Pharm Sci. 2021 May;110(5):1869-1870. doi: 10.1016/j.xphs.2020.10.053. Epub 2020 Nov 13. J Pharm Sci. 2021. PMID: 33189694 No abstract available.

6

Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems.

Kraft JC, Freeling JP, Wang Z, Ho RJ. Kraft JC, et al. Among authors: ho rj. J Pharm Sci. 2014 Jan;103(1):29-52. doi: 10.1002/jps.23773. Epub 2013 Nov 25. J Pharm Sci. 2014. PMID: 24338748 Free PMC article. Review.

7

Warp-Speed Covid-19 Vaccine Development: Beneficiaries of Maturation in Biopharmaceutical Technologies and Public-Private Partnerships.

Ho RJY. Ho RJY. J Pharm Sci. 2021 Feb;110(2):615-618. doi: 10.1016/j.xphs.2020.11.010. Epub 2020 Nov 17. J Pharm Sci. 2021. PMID: 33212162 Free PMC article.

8

Nanodrug formulations to enhance HIV drug exposure in lymphoid tissues and cells: clinical significance and potential impact on treatment and eradication of HIV/AIDS.

Shao J, Kraft JC, Li B, Yu J, Freeling J, Koehn J, Ho RJ. Shao J, et al. Among authors: ho rj. Nanomedicine (Lond). 2016;11(5):545-64. doi: 10.2217/nnm.16.1. Epub 2016 Feb 19. Nanomedicine (Lond). 2016. PMID: 26892323 Free PMC article. Review.

9

Challenges and opportunities in metastatic breast cancer treatments: Nano-drug combinations delivered preferentially to metastatic cells may enhance therapeutic response.

Yu J, Mu Q, Fung M, Xu X, Zhu L, Ho RJY. Yu J, et al. Among authors: ho rjy. Pharmacol Ther. 2022 Jan 6:108108. doi: 10.1016/j.pharmthera.2022.108108. Online ahead of print. Pharmacol Ther. 2022. PMID: 34999182 Review.

10

Systems and Clinical Pharmacology of COVID-19 Therapeutic Candidates: A Clinical and Translational Medicine Perspective.

Perazzolo S, Zhu L, Lin W, Nguyen A, Ho RJY. Perazzolo S, et al. Among authors: ho rjy. J Pharm Sci. 2021 Mar;110(3):1002-1017. doi: 10.1016/j.xphs.2020.11.019. Epub 2020 Nov 26. J Pharm Sci. 2021. PMID: 33248057 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results